The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pril-series Drugs API Market Research Report 2025
Synopsis
Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure.
The global Pril-series Drugs API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pril-series Drugs API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pril-series Drugs API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pril-series Drugs API include Huahai Pharmaceutical, Zhejiang Changming Pharmaceutical, Dr. Reddy's Laboratories, Glenmark, ScinoPharm, Novartis Pharma, Sun Pharmaceutical, Farmhispania, Medichem, Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pril-series Drugs API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pril-series Drugs API.
The Pril-series Drugs API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pril-series Drugs API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pril-series Drugs API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Huahai Pharmaceutical
Zhejiang Changming Pharmaceutical
Dr. Reddy's Laboratories
Glenmark
ScinoPharm
Novartis Pharma
Sun Pharmaceutical
Farmhispania
Medichem
Hetero
Siegfried Evionnaz
Changzhou Pharmaceutical Factory
Chongqing Southwest No. 2 Pharmaceutical Factory
Ningbo Menovo Pharmaceutical
Segment by Type
Enalapril
Lisinopril
Captopril
Ramipril
Perindopril
Benazepril
Others
Segment by Application
Tablets
Capsules
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pril-series Drugs API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pril-series Drugs API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure.
The global Pril-series Drugs API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pril-series Drugs API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pril-series Drugs API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pril-series Drugs API include Huahai Pharmaceutical, Zhejiang Changming Pharmaceutical, Dr. Reddy's Laboratories, Glenmark, ScinoPharm, Novartis Pharma, Sun Pharmaceutical, Farmhispania, Medichem, Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pril-series Drugs API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pril-series Drugs API.
The Pril-series Drugs API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pril-series Drugs API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pril-series Drugs API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Huahai Pharmaceutical
Zhejiang Changming Pharmaceutical
Dr. Reddy's Laboratories
Glenmark
ScinoPharm
Novartis Pharma
Sun Pharmaceutical
Farmhispania
Medichem
Hetero
Siegfried Evionnaz
Changzhou Pharmaceutical Factory
Chongqing Southwest No. 2 Pharmaceutical Factory
Ningbo Menovo Pharmaceutical
Segment by Type
Enalapril
Lisinopril
Captopril
Ramipril
Perindopril
Benazepril
Others
Segment by Application
Tablets
Capsules
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pril-series Drugs API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pril-series Drugs API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pril-series Drugs API Market Overview
1.1 Product Definition
1.2 Pril-series Drugs API by Type
1.2.1 Global Pril-series Drugs API Market Value Comparison by Type (2024-2030)
1.2.2 Enalapril
1.2.3 Lisinopril
1.2.4 Captopril
1.2.5 Ramipril
1.2.6 Perindopril
1.2.7 Benazepril
1.2.8 Others
1.3 Pril-series Drugs API by Application
1.3.1 Global Pril-series Drugs API Market Value by Application (2024-2030)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Pril-series Drugs API Market Size Estimates and Forecasts
1.4.1 Global Pril-series Drugs API Revenue 2019-2030
1.4.2 Global Pril-series Drugs API Sales 2019-2030
1.4.3 Global Pril-series Drugs API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pril-series Drugs API Market Competition by Manufacturers
2.1 Global Pril-series Drugs API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pril-series Drugs API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pril-series Drugs API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pril-series Drugs API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pril-series Drugs API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pril-series Drugs API, Product Type & Application
2.7 Global Key Manufacturers of Pril-series Drugs API, Date of Enter into This Industry
2.8 Global Pril-series Drugs API Market Competitive Situation and Trends
2.8.1 Global Pril-series Drugs API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pril-series Drugs API Players Market Share by Revenue
2.8.3 Global Pril-series Drugs API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pril-series Drugs API Market Scenario by Region
3.1 Global Pril-series Drugs API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pril-series Drugs API Sales by Region: 2019-2030
3.2.1 Global Pril-series Drugs API Sales by Region: 2019-2024
3.2.2 Global Pril-series Drugs API Sales by Region: 2025-2030
3.3 Global Pril-series Drugs API Revenue by Region: 2019-2030
3.3.1 Global Pril-series Drugs API Revenue by Region: 2019-2024
3.3.2 Global Pril-series Drugs API Revenue by Region: 2025-2030
3.4 North America Pril-series Drugs API Market Facts & Figures by Country
3.4.1 North America Pril-series Drugs API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pril-series Drugs API Sales by Country (2019-2030)
3.4.3 North America Pril-series Drugs API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pril-series Drugs API Market Facts & Figures by Country
3.5.1 Europe Pril-series Drugs API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pril-series Drugs API Sales by Country (2019-2030)
3.5.3 Europe Pril-series Drugs API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pril-series Drugs API Market Facts & Figures by Region
3.6.1 Asia Pacific Pril-series Drugs API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pril-series Drugs API Sales by Region (2019-2030)
3.6.3 Asia Pacific Pril-series Drugs API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pril-series Drugs API Market Facts & Figures by Country
3.7.1 Latin America Pril-series Drugs API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pril-series Drugs API Sales by Country (2019-2030)
3.7.3 Latin America Pril-series Drugs API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pril-series Drugs API Market Facts & Figures by Country
3.8.1 Middle East and Africa Pril-series Drugs API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pril-series Drugs API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pril-series Drugs API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pril-series Drugs API Sales by Type (2019-2030)
4.1.1 Global Pril-series Drugs API Sales by Type (2019-2024)
4.1.2 Global Pril-series Drugs API Sales by Type (2025-2030)
4.1.3 Global Pril-series Drugs API Sales Market Share by Type (2019-2030)
4.2 Global Pril-series Drugs API Revenue by Type (2019-2030)
4.2.1 Global Pril-series Drugs API Revenue by Type (2019-2024)
4.2.2 Global Pril-series Drugs API Revenue by Type (2025-2030)
4.2.3 Global Pril-series Drugs API Revenue Market Share by Type (2019-2030)
4.3 Global Pril-series Drugs API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pril-series Drugs API Sales by Application (2019-2030)
5.1.1 Global Pril-series Drugs API Sales by Application (2019-2024)
5.1.2 Global Pril-series Drugs API Sales by Application (2025-2030)
5.1.3 Global Pril-series Drugs API Sales Market Share by Application (2019-2030)
5.2 Global Pril-series Drugs API Revenue by Application (2019-2030)
5.2.1 Global Pril-series Drugs API Revenue by Application (2019-2024)
5.2.2 Global Pril-series Drugs API Revenue by Application (2025-2030)
5.2.3 Global Pril-series Drugs API Revenue Market Share by Application (2019-2030)
5.3 Global Pril-series Drugs API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Huahai Pharmaceutical
6.1.1 Huahai Pharmaceutical Company Information
6.1.2 Huahai Pharmaceutical Description and Business Overview
6.1.3 Huahai Pharmaceutical Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Huahai Pharmaceutical Pril-series Drugs API Product Portfolio
6.1.5 Huahai Pharmaceutical Recent Developments/Updates
6.2 Zhejiang Changming Pharmaceutical
6.2.1 Zhejiang Changming Pharmaceutical Company Information
6.2.2 Zhejiang Changming Pharmaceutical Description and Business Overview
6.2.3 Zhejiang Changming Pharmaceutical Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zhejiang Changming Pharmaceutical Pril-series Drugs API Product Portfolio
6.2.5 Zhejiang Changming Pharmaceutical Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Company Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Pril-series Drugs API Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Glenmark
6.4.1 Glenmark Company Information
6.4.2 Glenmark Description and Business Overview
6.4.3 Glenmark Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Glenmark Pril-series Drugs API Product Portfolio
6.4.5 Glenmark Recent Developments/Updates
6.5 ScinoPharm
6.5.1 ScinoPharm Company Information
6.5.2 ScinoPharm Description and Business Overview
6.5.3 ScinoPharm Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ScinoPharm Pril-series Drugs API Product Portfolio
6.5.5 ScinoPharm Recent Developments/Updates
6.6 Novartis Pharma
6.6.1 Novartis Pharma Company Information
6.6.2 Novartis Pharma Description and Business Overview
6.6.3 Novartis Pharma Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Pharma Pril-series Drugs API Product Portfolio
6.6.5 Novartis Pharma Recent Developments/Updates
6.7 Sun Pharmaceutical
6.7.1 Sun Pharmaceutical Company Information
6.7.2 Sun Pharmaceutical Description and Business Overview
6.7.3 Sun Pharmaceutical Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Sun Pharmaceutical Pril-series Drugs API Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Farmhispania
6.8.1 Farmhispania Company Information
6.8.2 Farmhispania Description and Business Overview
6.8.3 Farmhispania Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Farmhispania Pril-series Drugs API Product Portfolio
6.8.5 Farmhispania Recent Developments/Updates
6.9 Medichem
6.9.1 Medichem Company Information
6.9.2 Medichem Description and Business Overview
6.9.3 Medichem Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medichem Pril-series Drugs API Product Portfolio
6.9.5 Medichem Recent Developments/Updates
6.10 Hetero
6.10.1 Hetero Company Information
6.10.2 Hetero Description and Business Overview
6.10.3 Hetero Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hetero Pril-series Drugs API Product Portfolio
6.10.5 Hetero Recent Developments/Updates
6.11 Siegfried Evionnaz
6.11.1 Siegfried Evionnaz Company Information
6.11.2 Siegfried Evionnaz Description and Business Overview
6.11.3 Siegfried Evionnaz Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Siegfried Evionnaz Pril-series Drugs API Product Portfolio
6.11.5 Siegfried Evionnaz Recent Developments/Updates
6.12 Changzhou Pharmaceutical Factory
6.12.1 Changzhou Pharmaceutical Factory Company Information
6.12.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.12.3 Changzhou Pharmaceutical Factory Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Changzhou Pharmaceutical Factory Pril-series Drugs API Product Portfolio
6.12.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
6.13 Chongqing Southwest No. 2 Pharmaceutical Factory
6.13.1 Chongqing Southwest No. 2 Pharmaceutical Factory Company Information
6.13.2 Chongqing Southwest No. 2 Pharmaceutical Factory Description and Business Overview
6.13.3 Chongqing Southwest No. 2 Pharmaceutical Factory Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chongqing Southwest No. 2 Pharmaceutical Factory Pril-series Drugs API Product Portfolio
6.13.5 Chongqing Southwest No. 2 Pharmaceutical Factory Recent Developments/Updates
6.14 Ningbo Menovo Pharmaceutical
6.14.1 Ningbo Menovo Pharmaceutical Company Information
6.14.2 Ningbo Menovo Pharmaceutical Description and Business Overview
6.14.3 Ningbo Menovo Pharmaceutical Pril-series Drugs API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ningbo Menovo Pharmaceutical Pril-series Drugs API Product Portfolio
6.14.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pril-series Drugs API Industry Chain Analysis
7.2 Pril-series Drugs API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pril-series Drugs API Production Mode & Process
7.4 Pril-series Drugs API Sales and Marketing
7.4.1 Pril-series Drugs API Sales Channels
7.4.2 Pril-series Drugs API Distributors
7.5 Pril-series Drugs API Customers
8 Pril-series Drugs API Market Dynamics
8.1 Pril-series Drugs API Industry Trends
8.2 Pril-series Drugs API Market Drivers
8.3 Pril-series Drugs API Market Challenges
8.4 Pril-series Drugs API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pril-series Drugs API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pril-series Drugs API Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pril-series Drugs API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pril-series Drugs API Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Pril-series Drugs API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pril-series Drugs API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pril-series Drugs API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pril-series Drugs API Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pril-series Drugs API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pril-series Drugs API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pril-series Drugs API, Product Type & Application
Table 12. Global Key Manufacturers of Pril-series Drugs API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pril-series Drugs API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pril-series Drugs API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pril-series Drugs API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pril-series Drugs API Sales by Region (2019-2024) & (Tons)
Table 18. Global Pril-series Drugs API Sales Market Share by Region (2019-2024)
Table 19. Global Pril-series Drugs API Sales by Region (2025-2030) & (Tons)
Table 20. Global Pril-series Drugs API Sales Market Share by Region (2025-2030)
Table 21. Global Pril-series Drugs API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pril-series Drugs API Revenue Market Share by Region (2019-2024)
Table 23. Global Pril-series Drugs API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pril-series Drugs API Revenue Market Share by Region (2025-2030)
Table 25. North America Pril-series Drugs API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pril-series Drugs API Sales by Country (2019-2024) & (Tons)
Table 27. North America Pril-series Drugs API Sales by Country (2025-2030) & (Tons)
Table 28. North America Pril-series Drugs API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pril-series Drugs API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pril-series Drugs API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pril-series Drugs API Sales by Country (2019-2024) & (Tons)
Table 32. Europe Pril-series Drugs API Sales by Country (2025-2030) & (Tons)
Table 33. Europe Pril-series Drugs API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pril-series Drugs API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pril-series Drugs API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pril-series Drugs API Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Pril-series Drugs API Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Pril-series Drugs API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pril-series Drugs API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pril-series Drugs API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pril-series Drugs API Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Pril-series Drugs API Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Pril-series Drugs API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pril-series Drugs API Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pril-series Drugs API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pril-series Drugs API Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Pril-series Drugs API Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Pril-series Drugs API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pril-series Drugs API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pril-series Drugs API Sales (Tons) by Type (2019-2024)
Table 51. Global Pril-series Drugs API Sales (Tons) by Type (2025-2030)
Table 52. Global Pril-series Drugs API Sales Market Share by Type (2019-2024)
Table 53. Global Pril-series Drugs API Sales Market Share by Type (2025-2030)
Table 54. Global Pril-series Drugs API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pril-series Drugs API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pril-series Drugs API Revenue Market Share by Type (2019-2024)
Table 57. Global Pril-series Drugs API Revenue Market Share by Type (2025-2030)
Table 58. Global Pril-series Drugs API Price (US$/Kg) by Type (2019-2024)
Table 59. Global Pril-series Drugs API Price (US$/Kg) by Type (2025-2030)
Table 60. Global Pril-series Drugs API Sales (Tons) by Application (2019-2024)
Table 61. Global Pril-series Drugs API Sales (Tons) by Application (2025-2030)
Table 62. Global Pril-series Drugs API Sales Market Share by Application (2019-2024)
Table 63. Global Pril-series Drugs API Sales Market Share by Application (2025-2030)
Table 64. Global Pril-series Drugs API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pril-series Drugs API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pril-series Drugs API Revenue Market Share by Application (2019-2024)
Table 67. Global Pril-series Drugs API Revenue Market Share by Application (2025-2030)
Table 68. Global Pril-series Drugs API Price (US$/Kg) by Application (2019-2024)
Table 69. Global Pril-series Drugs API Price (US$/Kg) by Application (2025-2030)
Table 70. Huahai Pharmaceutical Company Information
Table 71. Huahai Pharmaceutical Description and Business Overview
Table 72. Huahai Pharmaceutical Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Huahai Pharmaceutical Pril-series Drugs API Product
Table 74. Huahai Pharmaceutical Recent Developments/Updates
Table 75. Zhejiang Changming Pharmaceutical Company Information
Table 76. Zhejiang Changming Pharmaceutical Description and Business Overview
Table 77. Zhejiang Changming Pharmaceutical Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Zhejiang Changming Pharmaceutical Pril-series Drugs API Product
Table 79. Zhejiang Changming Pharmaceutical Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Company Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Dr. Reddy's Laboratories Pril-series Drugs API Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Glenmark Company Information
Table 86. Glenmark Description and Business Overview
Table 87. Glenmark Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Glenmark Pril-series Drugs API Product
Table 89. Glenmark Recent Developments/Updates
Table 90. ScinoPharm Company Information
Table 91. ScinoPharm Description and Business Overview
Table 92. ScinoPharm Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. ScinoPharm Pril-series Drugs API Product
Table 94. ScinoPharm Recent Developments/Updates
Table 95. Novartis Pharma Company Information
Table 96. Novartis Pharma Description and Business Overview
Table 97. Novartis Pharma Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Novartis Pharma Pril-series Drugs API Product
Table 99. Novartis Pharma Recent Developments/Updates
Table 100. Sun Pharmaceutical Company Information
Table 101. Sun Pharmaceutical Description and Business Overview
Table 102. Sun Pharmaceutical Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Sun Pharmaceutical Pril-series Drugs API Product
Table 104. Sun Pharmaceutical Recent Developments/Updates
Table 105. Farmhispania Company Information
Table 106. Farmhispania Description and Business Overview
Table 107. Farmhispania Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Farmhispania Pril-series Drugs API Product
Table 109. Farmhispania Recent Developments/Updates
Table 110. Medichem Company Information
Table 111. Medichem Description and Business Overview
Table 112. Medichem Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Medichem Pril-series Drugs API Product
Table 114. Medichem Recent Developments/Updates
Table 115. Hetero Company Information
Table 116. Hetero Description and Business Overview
Table 117. Hetero Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Hetero Pril-series Drugs API Product
Table 119. Hetero Recent Developments/Updates
Table 120. Siegfried Evionnaz Company Information
Table 121. Siegfried Evionnaz Description and Business Overview
Table 122. Siegfried Evionnaz Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Siegfried Evionnaz Pril-series Drugs API Product
Table 124. Siegfried Evionnaz Recent Developments/Updates
Table 125. Changzhou Pharmaceutical Factory Company Information
Table 126. Changzhou Pharmaceutical Factory Description and Business Overview
Table 127. Changzhou Pharmaceutical Factory Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Changzhou Pharmaceutical Factory Pril-series Drugs API Product
Table 129. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 130. Chongqing Southwest No. 2 Pharmaceutical Factory Company Information
Table 131. Chongqing Southwest No. 2 Pharmaceutical Factory Description and Business Overview
Table 132. Chongqing Southwest No. 2 Pharmaceutical Factory Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Chongqing Southwest No. 2 Pharmaceutical Factory Pril-series Drugs API Product
Table 134. Chongqing Southwest No. 2 Pharmaceutical Factory Recent Developments/Updates
Table 135. Ningbo Menovo Pharmaceutical Company Information
Table 136. Ningbo Menovo Pharmaceutical Description and Business Overview
Table 137. Ningbo Menovo Pharmaceutical Pril-series Drugs API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Ningbo Menovo Pharmaceutical Pril-series Drugs API Product
Table 139. Ningbo Menovo Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Pril-series Drugs API Distributors List
Table 143. Pril-series Drugs API Customers List
Table 144. Pril-series Drugs API Market Trends
Table 145. Pril-series Drugs API Market Drivers
Table 146. Pril-series Drugs API Market Challenges
Table 147. Pril-series Drugs API Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pril-series Drugs API
Figure 2. Global Pril-series Drugs API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pril-series Drugs API Market Share by Type: 2023 & 2030
Figure 4. Enalapril Product Picture
Figure 5. Lisinopril Product Picture
Figure 6. Captopril Product Picture
Figure 7. Ramipril Product Picture
Figure 8. Perindopril Product Picture
Figure 9. Benazepril Product Picture
Figure 10. Others Product Picture
Figure 11. Global Pril-series Drugs API Market Value by Application (2024-2030) & (US$ Million)
Figure 12. Global Pril-series Drugs API Market Share by Application: 2023 & 2030
Figure 13. Tablets
Figure 14. Capsules
Figure 15. Others
Figure 16. Global Pril-series Drugs API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Pril-series Drugs API Market Size (2019-2030) & (US$ Million)
Figure 18. Global Pril-series Drugs API Sales (2019-2030) & (Tons)
Figure 19. Global Pril-series Drugs API Average Price (US$/Kg) & (2019-2030)
Figure 20. Pril-series Drugs API Report Years Considered
Figure 21. Pril-series Drugs API Sales Share by Manufacturers in 2023
Figure 22. Global Pril-series Drugs API Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Pril-series Drugs API Players: Market Share by Revenue in Pril-series Drugs API in 2023
Figure 24. Pril-series Drugs API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Pril-series Drugs API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Pril-series Drugs API Sales Market Share by Country (2019-2030)
Figure 27. North America Pril-series Drugs API Revenue Market Share by Country (2019-2030)
Figure 28. United States Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Pril-series Drugs API Sales Market Share by Country (2019-2030)
Figure 31. Europe Pril-series Drugs API Revenue Market Share by Country (2019-2030)
Figure 32. Germany Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Pril-series Drugs API Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Pril-series Drugs API Revenue Market Share by Region (2019-2030)
Figure 39. China Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Pril-series Drugs API Sales Market Share by Country (2019-2030)
Figure 47. Mexico Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Pril-series Drugs API Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Pril-series Drugs API Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Pril-series Drugs API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Pril-series Drugs API by Type (2019-2030)
Figure 57. Global Revenue Market Share of Pril-series Drugs API by Type (2019-2030)
Figure 58. Global Pril-series Drugs API Price (US$/Kg) by Type (2019-2030)
Figure 59. Global Sales Market Share of Pril-series Drugs API by Application (2019-2030)
Figure 60. Global Revenue Market Share of Pril-series Drugs API by Application (2019-2030)
Figure 61. Global Pril-series Drugs API Price (US$/Kg) by Application (2019-2030)
Figure 62. Pril-series Drugs API Value Chain
Figure 63. Pril-series Drugs API Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
